Argon Laser Photocoagulation for Neovascular Maculopathy: Five-Year Results From Randomized Clinical Trials

Archives of Ophthalmology

Volumn 109, Issue 8, 1991, Pages 1109-1114

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARGON; FLUORESCEIN;

ARGON LASER; ARTICLE; CHOROID VASCULARIZATION; CLINICAL TRIAL; CONTROLLED STUDY; HISTOPLASMOSIS; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RETINA MACULA DEGENERATION; RETINA MACULOPATHY; RISK FACTOR; VISUAL ACUITY; VISUAL IMPAIRMENT;

ARGON; CHOROID; FOLLOW-UP STUDIES; HUMAN; LASER SURGERY; LIGHT COAGULATION; MACULA LUTEA; NEOVASCULARIZATION, PATHOLOGIC; RECURRENCE; RETINAL DISEASES; SUPPORT, U.S. GOV'T, P.H.S.; VISUAL ACUITY;

EID: 0026409933     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archopht.1991.01080080069030     Document Type: Article

References (14)

1. Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1982;100:912-918.
2. Macular Photocoagulation Study Group. Argon laser photocoagulation for ocular histoplasmosis: results of a randomized clinical trial. Arch Ophthalmol. 1983;101:1347-1357.
3. Macular Photocoagulation Study Group. Argon laser photocoagulation for idiopathic neovascularization: results of a randomized clinical trial. Arch Ophthalmol. 1983;101:1358-1361.
4. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: three-year results from randomized clinical trials. Arch Ophthalmol. 1986;104:694-701.
5. Macular Photocoagulation Study Group. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol. 1986;104:503-512.
6. Macular Photocoagulation Study Group. Manual of Procedures. Springfield, Va: National Technical Information Service; 1991: Accession No. PB91-159368.
7. Macular Photocoagulation Study Group. Changing the protocol: a case report from the Macular Photocoagulation Study. Controlled Clin Trials. 1984;5:203-216.
8. Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Optic. 1976;53:740-745.
9. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130.
10. Snedecor GW, Cochran WG. Statistical Methods. 7th ed. Ames: Iowa State University Press; 1980:144-145.
11. Snedecor GW, Cochran WG. Statistical Methods. 7th ed. Ames: Iowa State University Press; 1980:89-95.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
13. Bressler SB, Maguire MG, Bressler NM, Fine SL, Macular Photocoagulation Study Group. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol. 1990;108:1442-1447.
14. Folk JC, Blackhurst DW, Alexander J, et al. Pretreatment fundus characteristics as predictors of recurrent choroidal neovascularization. Arch Ophthalmol. In press.